118 related articles for article (PubMed ID: 24727911)
1. Germline variation in colorectal risk Loci does not influence treatment effect or survival in metastatic colorectal cancer.
Sanoff HK; Renfro LA; Poonnen P; Ambadwar P; Sargent DJ; Goldberg RM; McLeod H
PLoS One; 2014; 9(4):e94727. PubMed ID: 24727911
[TBL] [Abstract][Full Text] [Related]
2. A retrospective observational study of the relationship between single nucleotide polymorphisms associated with the risk of developing colorectal cancer and survival.
Morris EJ; Penegar S; Whiffin N; Broderick P; Bishop DT; Northwood E; Quirke P; Finan P; Houlston RS
PLoS One; 2015; 10(2):e0117816. PubMed ID: 25710502
[TBL] [Abstract][Full Text] [Related]
3. Association of eleven common, low-penetrance colorectal cancer susceptibility genetic variants at six risk loci with clinical outcome.
Hoskins JM; Ong PS; Keku TO; Galanko JA; Martin CF; Coleman CA; Wolfe M; Sandler RS; McLeod HL
PLoS One; 2012; 7(7):e41954. PubMed ID: 22848671
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of colorectal cancer-risk loci and survival outcome: A prognostic role for CDH1 variants.
Summers MG; Maughan TS; Kaplan R; Law PJ; Houlston RS; Escott-Price V; Cheadle JP
Eur J Cancer; 2020 Jan; 124():56-63. PubMed ID: 31734605
[TBL] [Abstract][Full Text] [Related]
5. Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival.
Salimzadeh H; Lindskog EB; Gustavsson B; Wettergren Y; Ljungman D
BMC Cancer; 2020 May; 20(1):409. PubMed ID: 32397974
[TBL] [Abstract][Full Text] [Related]
6. Enrichment of low penetrance susceptibility loci in a Dutch familial colorectal cancer cohort.
Middeldorp A; Jagmohan-Changur S; van Eijk R; Tops C; Devilee P; Vasen HF; Hes FJ; Houlston R; Tomlinson I; Houwing-Duistermaat JJ; Wijnen JT; Morreau H; van Wezel T
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3062-7. PubMed ID: 19843678
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive meta-analysis of genetic associations between five key SNPs and colorectal cancer risk.
Hong Y; Wu G; Li W; Liu D; He K
Oncotarget; 2016 Nov; 7(45):73945-73959. PubMed ID: 27661122
[TBL] [Abstract][Full Text] [Related]
8. Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers?
Win AK; Hopper JL; Buchanan DD; Young JP; Tenesa A; Dowty JG; Giles GG; Goldblatt J; Winship I; Boussioutas A; Young GP; Parry S; Baron JA; Duggan D; Gallinger S; Newcomb PA; Haile RW; Le Marchand L; Lindor NM; Jenkins MA
Eur J Cancer; 2013 May; 49(7):1578-87. PubMed ID: 23434150
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in Lynch syndrome.
Talseth-Palmer BA; Brenne IS; Ashton KA; Evans TJ; McPhillips M; Groombridge C; Suchy J; Kurzawski G; Spigelman A; Lubinski J; Scott RJ
J Med Genet; 2011 Apr; 48(4):279-84. PubMed ID: 21097774
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility genetic variants associated with early-onset colorectal cancer.
Giráldez MD; López-Dóriga A; Bujanda L; Abulí A; Bessa X; Fernández-Rozadilla C; Muñoz J; Cuatrecasas M; Jover R; Xicola RM; Llor X; Piqué JM; Carracedo A; Ruiz-Ponte C; Cosme A; Enríquez-Navascués JM; Moreno V; Andreu M; Castells A; Balaguer F; Castellví-Bel S;
Carcinogenesis; 2012 Mar; 33(3):613-9. PubMed ID: 22235025
[TBL] [Abstract][Full Text] [Related]
11. Association studies on 11 published colorectal cancer risk loci.
von Holst S; Picelli S; Edler D; Lenander C; Dalén J; Hjern F; Lundqvist N; Lindforss U; Påhlman L; Smedh K; Törnqvist A; Holm J; Janson M; Andersson M; Ekelund S; Olsson L; Ghazi S; Papadogiannakis N; Tenesa A; Farrington SM; Campbell H; Dunlop MG; Lindblom A
Br J Cancer; 2010 Aug; 103(4):575-80. PubMed ID: 20648012
[TBL] [Abstract][Full Text] [Related]
12. A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3.
Tomlinson IP; Webb E; Carvajal-Carmona L; Broderick P; Howarth K; Pittman AM; Spain S; Lubbe S; Walther A; Sullivan K; Jaeger E; Fielding S; Rowan A; Vijayakrishnan J; Domingo E; Chandler I; Kemp Z; Qureshi M; Farrington SM; Tenesa A; Prendergast JG; Barnetson RA; Penegar S; Barclay E; Wood W; Martin L; Gorman M; Thomas H; Peto J; Bishop DT; Gray R; Maher ER; Lucassen A; Kerr D; Evans DG; ; Schafmayer C; Buch S; Völzke H; Hampe J; Schreiber S; John U; Koessler T; Pharoah P; van Wezel T; Morreau H; Wijnen JT; Hopper JL; Southey MC; Giles GG; Severi G; Castellví-Bel S; Ruiz-Ponte C; Carracedo A; Castells A; ; Försti A; Hemminki K; Vodicka P; Naccarati A; Lipton L; Ho JW; Cheng KK; Sham PC; Luk J; Agúndez JA; Ladero JM; de la Hoya M; Caldés T; Niittymäki I; Tuupanen S; Karhu A; Aaltonen L; Cazier JB; Campbell H; Dunlop MG; Houlston RS
Nat Genet; 2008 May; 40(5):623-30. PubMed ID: 18372905
[TBL] [Abstract][Full Text] [Related]
13. Association between colorectal cancer susceptibility loci and survival time after diagnosis with colorectal cancer.
Phipps AI; Newcomb PA; Garcia-Albeniz X; Hutter CM; White E; Fuchs CS; Hazra A; Ogino S; Nan H; Ma J; Campbell PT; Figueiredo JC; Peters U; Chan AT
Gastroenterology; 2012 Jul; 143(1):51-4.e4. PubMed ID: 22580541
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of TLR1 I602S Polymorphism for Patients with Metastatic Colorectal Cancer Treated with FOLFIRI plus Bevacizumab.
Okazaki S; Loupakis F; Stintzing S; Cao S; Zhang W; Yang D; Ning Y; Sunakawa Y; Stremitzer S; Matsusaka S; Berger MD; Parekh A; West JD; Miyamoto Y; Suenaga M; Schirripa M; Cremolini C; Falcone A; Heinemann V; DePaolo RW; Lenz HJ
Mol Cancer Ther; 2016 Jul; 15(7):1740-5. PubMed ID: 27196764
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer susceptibility loci in a population-based study: Associations with morphological parameters.
Ghazi S; von Holst S; Picelli S; Lindforss U; Tenesa A; Farrington SM; Campbell H; Dunlop MG; Papadogiannakis N; Lindblom A;
Am J Pathol; 2010 Dec; 177(6):2688-93. PubMed ID: 21119214
[TBL] [Abstract][Full Text] [Related]
16. Expression quantitative trait loci in ABC transporters are associated with survival in 5-FU treated colorectal cancer patients.
Vymetalkova V; Rosa F; Susova S; Bendova P; Levy M; Buchler T; Kral J; Bartu L; Vodickova L; Hughes DJ; Soucek P; Naccarati A; Kumar R; Vodicka P; Pardini B
Mutagenesis; 2020 Jul; 35(3):273-281. PubMed ID: 31922572
[TBL] [Abstract][Full Text] [Related]
17. Generalizability and epidemiologic characterization of eleven colorectal cancer GWAS hits in multiple populations.
He J; Wilkens LR; Stram DO; Kolonel LN; Henderson BE; Wu AH; Le Marchand L; Haiman CA
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):70-81. PubMed ID: 21071539
[TBL] [Abstract][Full Text] [Related]
18. Colorectal cancer susceptibility loci as predictive markers of rectal cancer prognosis after surgery.
Hu Y; Gaedcke J; Emons G; Beissbarth T; Grade M; Jo P; Yeager M; Chanock SJ; Wolff H; Camps J; Ghadimi BM; Ried T
Genes Chromosomes Cancer; 2018 Mar; 57(3):140-149. PubMed ID: 29119627
[TBL] [Abstract][Full Text] [Related]
19. Systematic search for enhancer elements and somatic allelic imbalance at seven low-penetrance colorectal cancer predisposition loci.
Niittymäki I; Tuupanen S; Li Y; Järvinen H; Mecklin JP; Tomlinson IP; Houlston RS; Karhu A; Aaltonen LA
BMC Med Genet; 2011 Feb; 12():23. PubMed ID: 21314996
[TBL] [Abstract][Full Text] [Related]
20. SNPs in the coding region of the metastasis-inducing gene MACC1 and clinical outcome in colorectal cancer.
Schmid F; Burock S; Klockmeier K; Schlag PM; Stein U
Mol Cancer; 2012 Jul; 11():49. PubMed ID: 22838389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
